Spatial memory improvement by levodopa in Parkinsonian MPTP-treated monkeys

Psychopharmacology

Volumn 147, Issue 1, 1999, Pages 104-107

  Fernández Ruiz, Juan ^a,c   Doudet, Doris ^b   Aigner, Thomas G ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Dopamine; Levodopa; Memory; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; LEVODOPA;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RHESUS MONKEY; SPATIAL MEMORY; WORKING MEMORY;

ANIMALS; ANTIPARKINSON AGENTS; DIHYDROXYPHENYLALANINE; DOPAMINE AGENTS; FLUORINE RADIOISOTOPES; LEVODOPA; MACACA MULATTA; MALE; MEMORY; MOTOR ACTIVITY; MPTP POISONING; PARKINSON DISEASE, SECONDARY; PSYCHOMOTOR PERFORMANCE; SPACE PERCEPTION;

EID: 0033988717     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051148     Document Type: Article

References (19)

1. Bachevalier J, Landis LS, Walker LC, Brickson M, Mishkin M, Price DL, Cork LC (1991) Aged monkeys exhibit behavioral deficits indicative of widespread cerebral dysfunction. Neurobiol Aging 12:99-111
2. Battig K, Rosvold HE, Mishkin M (1960) Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys. J Comp Physiol Psychol 53:400-404
3. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of Rhesus monkey. Science 205:929-931
4. DiMonte D, Langston JW (1993) MPTP-induced parkinsonism in nonhuman primates. In: Schneider JS, Gupta M (eds) Current concepts in parkinson's disease research. Hogrefe & Huber, Washington, pp 159-179
5. 18F-L-Dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys. Exp Brain Res 78:69-80
6. 18F] Fluoro-L-dopa PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Synapse 29:3 225-32
7. Dubois B, Boller F, Pillon B, Agid Y (1991) Cognitive deficits in Parkinson's disease. In: Boller F, Grafman J (eds) Handbook of neuropsychology, vol 5. Elsevier, Amsterdam, pp 195-240
8. Fernandez-Ruiz J, Doudet DJ, Aigner TG (1995) Long-term cognitive impairment in MPTP-treated rhesus monkeys. Neuroreport 7:102-104
9. Gotham A-M, Brown RG, Marsden CD (1988) "Frontal" cognitive functions in patients with Parkinson's disease "on" and "off" L-dopa. Brain 111:299-332
10. Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM (1992) L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107:394-404
11. Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
12. Mitchell IJ, Cross AJ, Sambrook MA, Crossman AR (1985) Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus. Neurosci Lett 61:195-200
13. Mohr E, Fabbrini G, Ruggieri S, Fedio P, Chase T (1987) Cognitive concomitants of dopamine system stimulation in parkinsonian patients. J Neurol Neurosurg Psychiatry 50:1192-1196
14. Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP, Lange KW, Robbins TW (1992) Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115:1727-1751
15. Poewe W, Berger W, Benke TH, Schelosky L (1991) High-speed memory scanning in Parkinson's disease: Adverse effects of levodopa. Ann Neurol 29:670-673
16. Schneider JS, Kovelowski, CJ II (1990) Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys. Brain Res 519:122-128
17. Schneider JS, Roeltgen DP (1993) Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys. Brain Res 615:351-354
18. Schneider JS, Sun Z-Q, Roeltgen DP (1994) Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys. Pharmacol Biochem Behav 48:235-240
19. Stern Y, Tetrud JW, Martin WRW, Kutner SJ, Langston JW (1990) Cognitive change following MPTP exposure. Neurology 40:261-264